Day: March 9, 2026

LAS VEGAS, Nevada, March 09, 2026 (GLOBE NEWSWIRE) — Consumer Portfolio Services, Inc. (Nasdaq: CPSS) (“CPS” or the “Company”) today announced that it will hold a conference call on Wednesday, March 11, 2026 at 1:00 p.m. ET to discuss its fourth quarter 2025 operating results. Those wishing to participate can pre-register for the conference call at the following link https://register-conf.media-server.com/register/BI939b54a85b184d6b8c4cb82440102b17. Registered participants will receive an email containing conference call details for dial-in options. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the schedule start time. A replay will be available beginning two hours after conclusion of the call for 12 months via the Company’s website at https://ir.consumerportfolio.com/investor-relations. About...

MAX Power Saskatchewan Natural Hydrogen Documentary Videohttps://www.maxpowermining.com/NaturalHydrogen-NewEra/ SASKATOON, Saskatchewan, March 09, 2026 (GLOBE NEWSWIRE) — MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF; FSE: 89N) (“MAX Power” or the “Company”) announces that the Board of Directors of the Company has adopted a Shareholder Rights Plan and has entered into a Shareholder Rights Plan Agreement with TMX Trust Company as Rights Agent effective today. The Shareholder Rights Plan is consistent with rights plans adopted by other Canadian public companies and has not been adopted in response to any specific proposal or intention to acquire control of MAX Power. In the event of an unsolicited takeover bid in the future, the purpose of the Shareholder Rights Plan is to provide the Board and shareholders of MAX Power with an adequate...

CORAL GABLES, Fla., March 09, 2026 (GLOBE NEWSWIRE) — Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology and central nervous system disorders, today announced that Sergio Traversa, Chief Executive Officer, and Maged Shenouda, Chief Financial Officer, will participate in the Leerink Partners Global Healthcare Conference being held in Miami, Florida, from March 8-11, 2026. Leerink Partners Global Healthcare Conference DetailsFormat: Fireside ChatDate Tuesday, March 10, 2026Time: 8:40 AM ETWebcast: Click Here Management will also be available for one-one-one investor meetings during the conference. Please contact your Leerink Partners representative to schedule a meeting. The webcast can also be accessed on the Events page the Investors...

LAKEWOOD, Colo., March 09, 2026 (GLOBE NEWSWIRE) —  Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa” or “the Company”), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced that Gary Owens will step down as President and CEO on April 12, 2026, and will enable a smooth leadership transition. “Gary has served as Mesa’s CEO since 2017, leading Mesa through a period of significant growth, expansion into new markets, the maturation of the company’s foundation, and the implementation of The Mesa Way business system,” said John Sullivan, Chair of the Board. “We are grateful for his leadership and wish him continued success.” To lead the Company’s next chapter, the Board of Directors has appointed Dr. Siddhartha Kadia as President and Chief Executive Officer, effective...

V2G Is Here — Xos Enters ProductionThe connection that changes everything. V2G production begins April 2026.V2G production scheduled for April 2026 on one of North America’s largest school bus platforms, enabling fleets to return energy to the grid and offset operating costs Bidirectional technology roadmap will extend across Xos’s product portfolioLOS ANGELES, March 09, 2026 (GLOBE NEWSWIRE) — Xos, Inc. (NASDAQ: XOS) (“Xos” or the “Company”), a leader in electric commercial vehicles and mobile charging solutions, today announced V2G (Vehicle-to-Grid) production beginning in April 2026 on a major electric school bus platform in North America, with a clear roadmap to extend bidirectional capability across its product portfolio, including step vans, powertrains, and energy storage solutions. Building on its track record...

RIDGELAND, Miss., March 09, 2026 (GLOBE NEWSWIRE) — Cal-Maine Foods, Inc. (NASDAQ: CALM), the largest egg company in the United States and a leading player in the egg-based prepared food industry, today announced it will report results for its fiscal 2026 third quarter at approximately 6:00 a.m. ET on Wednesday, April 1, 2026. The earnings release will be available on the Cal-Maine Foods website at https://www.calmainefoods.com/press-releases. Management will review the results during a conference call and webcast at 9:00 a.m. ET the same day. Participants can access the live webcast on the Investor Relations page of the Cal-Maine Foods website at https://www.calmainefoods.com/events-presentations. To join by telephone, participants can register in advance here. Upon registering, participants will receive the dial-in info and a...

– The FDA assigned a PDUFA target action date of December 22, 2026 – – The NDA is based on positive data from a successful clinical program demonstrating favorable safety and blood pressure reduction in adults with hypertension – – Topline results from the Phase 2 Explore-OSA exploratory trial did not reduce AHI; demonstrated a clinically meaningful reduction in blood pressure and favorable safety and tolerability in this population with difficult to control hypertension – RADNOR, Pa., March 09, 2026 (GLOBE NEWSWIRE) — Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, announced today that the U.S. Food and...